Return to Main Menu

Individuals receive award recognition for patents During the second annual Biomedical Innovation Lecture, technology expert John E. Abele spoke about managing the explosion of technology and information in medicine. In addition to Abele's lecture, the MUSC Foundation for Research Development recognized individuals for the development of medical technology at MUSC which has led to the award of U.S. patents: Charles H. Kellner, M.D.; Cherry W. Jackson, Pharm.D.; and C. Lindsay DeVane, Pharm.D., all of the Department of Psychiatry, “Composition and Methods for Treating Performance Anxiety” J. Warren Bradley and Richard L. Wilson, Clinical and Respiratory Services, “Endotracheal Tube Fixation Device and Method of Using the Same” Peter B. Cotton, M.D., Digestive Disease Center, Department of Medicine, “Apparatus for Performing Diagnostic and Therapeutic Modalities in the Biliary Tree” Christian Schwabe, DDS., Ph.D.; Department of Biochemistry and Molecular Biology, “Relaxin Analogs and Derivatives Methods and Uses Thereof” James S. Norris, Ph.D., Department of Microbiology and Immunology, “Tissue Specific and Target RNA-Specific Ribozymes” Thomas Gettys, Ph.D., Department of Medicine; 7 M.D., Ph.D., Department of Medicine, “Methods of Treating Non-Insulin Dependent Diabetes Mellitus with Pancreatic Polypeptide” Ian L. Taylor, M.D., Ph.D., Department of Medicine, “Method of Treating Birds in Ovo” Sebastiano Gattoni-Celli, M.D., Department of Radiation Oncology; Joseph M. Jenrette, M.D., Edward F. McClay, M.D., formerly with the Division of Hematology and Oncology, Department of Medicine, “Method of Treating Neoplastic cells with Prostaglandin and Radiation Treatment or Prostaglandin with Platinum-based Anti-tumor agents” Jaymin C. Shah, Ph.D., formerly with Department of Pharmacy Science “Glyceryl Monosterate Based Biodegradable Implants for Site-Specific Delivery of Drugs” Inderjit Singh, Ph.D., Department of Pediatrics, “Compounds for Reducing Ischemia/Reperfusion Injury” Stephen J. Nelson, Department of Radiation Oncology; Chan F. Lam, Ph.D., Department of Biology and Epidemiology, “Computer Controlled Collimator Changer” Lee Chao, Ph.D., and Julie Chao, Ph.D., Department of Biochemistry and Molecular Biology, “Methods and Compositions of Correlating Tissue Kallikrein Gene Promoter Polymorphisms with Essential Hypertension”